|
|
Zavesca.com: Welcome
Description: Zavesca.com reviews the clinical data, efficacy, safety, administration, and mechanism of action of Zavesca (miglustat) the first and only oral substrate reduction therapy.
Keywords: zavesca
miglustat
vevesca
ogt-918
gaucher disease
type I gaucher disease
substrate reduction therapy
glucocerebrosidase
glycosphingolipid
glucocylceramide
jewish genetic disease
ashkenazi jewish disease
lysosomal storage disease
lipid storage disorder
Tags:
zavesca,
com,
information,
welcome,
safety,
prescribing,
full,
important,
contact,
disease,
therapy,
miglustat,
reduction,
substrate,
storage,
jewish,
gaucher,
clinical,
data,
reviews,
efficacy,
only,
administration,
oral,
first,
action,
mechanism,
Zavesca.com
Content Revalency:
Title: 0.00%
Description: 0.00%
Keywords: 0.00% | Document size: 5,207 bytes
More info:
Whois -
Trace Route -
RBL Check
| ZAVESCA.COM - Site Location |
| Country/Flag |
 United States |
| City/Region/Zip Code |
, , |
| Organization |
Massachusetts Institute of Technology |
| Internet Service Provider |
Massachusetts Institute of Technology |
|
ZAVESCA.COM - Domain Information |
| Domain |
ZAVESCA.COM [ Traceroute RBL/DNSBL lookup ] |
| Registrar |
Key-Systems GmbH Key-Systems GmbH |
| Whois server |
whois.verisign-grs.com |
| Created |
26-Jul-2002 |
| Updated |
25-Jun-2022 |
| Expires |
26-Jul-2023 |
| Time Left |
0 days 0 hours 0 minutes |
| Status |
clientTransferProhibited https://icann.org/epp#clientTransferProhibited clientTransferProhibited https://icann.org/epp#clientTransferProhibited |
| DNS servers |
NS0049.SECONDARY.CLOUDFLARE.COM 162.159.32.50
NS0202.SECONDARY.CLOUDFLARE.COM 162.159.33.77
ns0049.secondary.cloudflare.com 162.159.32.50
ns0202.secondary.cloudflare.com 162.159.33.77
|
| Site Response Header |
| Response |
HTTP/1.1 200 OK |
| Server |
Microsoft-IIS/6.0 |
| Date |
Tue, 16 Jun 2009 14:04:51 GMT |
| Content-Type |
text/html |
|
